UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,992,253 | +23.9% | 2,681,409 | +111.6% | 0.00% | +100.0% |
| Q2 2023 | $14,524,977 | -39.1% | 1,267,450 | +6.9% | 0.00% | -66.7% |
| Q1 2023 | $23,869,566 | -0.8% | 1,185,182 | +11.7% | 0.00% | 0.0% |
| Q4 2022 | $24,057,246 | +30.1% | 1,061,193 | +7.7% | 0.00% | 0.0% |
| Q3 2022 | $18,493,000 | -25.2% | 985,764 | -25.7% | 0.00% | 0.0% |
| Q2 2022 | $24,737,000 | -0.4% | 1,327,173 | -3.4% | 0.00% | 0.0% |
| Q1 2022 | $24,831,000 | -3.6% | 1,374,179 | +10.7% | 0.00% | 0.0% |
| Q4 2021 | $25,753,000 | +171.0% | 1,241,761 | +318.3% | 0.00% | +200.0% |
| Q3 2021 | $9,502,000 | +191.8% | 296,829 | +180.7% | 0.00% | – |
| Q2 2021 | $3,256,000 | +96.3% | 105,734 | +114.4% | 0.00% | – |
| Q1 2021 | $1,659,000 | +17.8% | 49,307 | +26.6% | 0.00% | – |
| Q4 2020 | $1,408,000 | -44.2% | 38,961 | -43.2% | 0.00% | – |
| Q3 2020 | $2,525,000 | -10.6% | 68,583 | +9.5% | 0.00% | -100.0% |
| Q2 2020 | $2,824,000 | +27.6% | 62,646 | +34.3% | 0.00% | 0.0% |
| Q1 2020 | $2,214,000 | -50.6% | 46,654 | -25.4% | 0.00% | 0.0% |
| Q4 2019 | $4,479,000 | +114.3% | 62,502 | +17.7% | 0.00% | 0.0% |
| Q3 2019 | $2,090,000 | -52.4% | 53,093 | -5.5% | 0.00% | 0.0% |
| Q2 2019 | $4,392,000 | +13.9% | 56,194 | -13.0% | 0.00% | 0.0% |
| Q1 2019 | $3,855,000 | +156.3% | 64,622 | +23.9% | 0.00% | – |
| Q4 2018 | $1,504,000 | -88.3% | 52,171 | -85.2% | 0.00% | -100.0% |
| Q3 2018 | $12,845,000 | -51.5% | 352,951 | -49.7% | 0.00% | -57.1% |
| Q2 2018 | $26,508,000 | +51.3% | 701,259 | -5.9% | 0.01% | +40.0% |
| Q1 2018 | $17,517,000 | +1.1% | 745,419 | -15.7% | 0.01% | 0.0% |
| Q4 2017 | $17,328,000 | +154.9% | 884,542 | +24.9% | 0.01% | +150.0% |
| Q3 2017 | $6,799,000 | +75.5% | 708,135 | +13.2% | 0.00% | +100.0% |
| Q2 2017 | $3,873,000 | -40.8% | 625,707 | -44.7% | 0.00% | 0.0% |
| Q1 2017 | $6,542,000 | +18.6% | 1,131,520 | +14.9% | 0.00% | 0.0% |
| Q4 2016 | $5,516,000 | +151.9% | 984,684 | +243.8% | 0.00% | 0.0% |
| Q3 2016 | $2,190,000 | -24.9% | 286,413 | -27.6% | 0.00% | 0.0% |
| Q2 2016 | $2,915,000 | +675.3% | 395,603 | +1149.4% | 0.00% | – |
| Q1 2016 | $376,000 | -17.0% | 31,663 | +15.8% | 0.00% | – |
| Q4 2015 | $453,000 | +55.7% | 27,345 | +91.9% | 0.00% | – |
| Q3 2015 | $291,000 | +7.4% | 14,250 | +41.8% | 0.00% | – |
| Q2 2015 | $271,000 | -84.3% | 10,050 | -85.9% | 0.00% | -100.0% |
| Q1 2015 | $1,730,000 | +444.0% | 71,136 | +230.7% | 0.00% | – |
| Q4 2014 | $318,000 | +31700.0% | 21,513 | +21413.0% | 0.00% | – |
| Q3 2014 | $1,000 | -96.4% | 100 | -95.2% | 0.00% | – |
| Q2 2014 | $28,000 | -97.4% | 2,089 | -96.9% | 0.00% | – |
| Q1 2014 | $1,057,000 | – | 67,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |